Patent Classification

Treatment, Damages, Reactive Oxygen Metabolites Related

1. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Treatment, Degenerative Disc Disease

1. Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix

Treatment, Demyelinating Conditions

1. Method for treating a demyelinating condition

Treatment, Dengue Fever

1. Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
    
2. Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
    
3. Membrane virus host range mutations and their uses as vaccine substrates
    
4. DNA or RNA encoding a recombinant dengue envelope protein
    
5. Attenuated dengue-2 virus vaccine

Treatment, Dermatitis

1. Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
    
2. Topical composition and method for the treatment and prophylaxis of dermal irritations
    
3. Use of gamma globulin for the topical treatment of lesions of dermatitis
    
4. Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
    
5. Method for detection of biological factors in epidermis
    
6. Allergic contact dermatitis treatment and composition therefor
    
7. Antihistamine sprays and ointments for relief of delayed contact dermatitis

Treatment, Detoxification

1. Detoxification and decontamination using nanotechnology therapy
    
2. Enterotoxin adsorbent, method of adsorptive removal, and adsorption apparatus
    
3. Method and composition for the accelerated in vivo removal of ethanol
    
4. Adsorbent for oral administration

Treatment, Diabetes/Glucagonemia

1. Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
    
2. Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31
    
3. Methods for identifying compounds for the treatment of type 1 diabetes
    
4. Methods for promoting growth and survival of insulin-secreting cells
    
5. Stimuli-responsive systems for controlled drug delivery
    
6. Process for the preparation of insulin conjugate IN-105
    
7. Techniques to improve polyurethane membranes for implantable glucose sensors
    
8. Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same
    
9. Method of blunting the postprandial glycemic response to a meal
    
10. Compositions of atomized or lyophilized maca (Lepidium meyenii) extracts and atomized or lyophilized yacon (Smallanthus sanchifolius) extracts as adjuvants in the treatment of different conditions
     
11. Plant extracts for treating skin disorders and enhancing healing of wounds for diabetic patients
     
12. Treatment of endothelial dysfunction in diabetic patients
     
13. Superior control of blood glucose in diabetes treatment
     
14. Methods for screening for compounds that modulate insulin promoter activity
     
15. Nutraceutical treatments for diabetic and non-diabetic wound healing
     
16. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
     
17. Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes
     
18. Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
     
19. Method of treating a nerve-related vision disorder in a non-diabetic subject
     
20. Methods and compositions for controlling appetite and modulating insulin sensitivity
     
21. Acidic insulin preparations having improved stability
     
22. Method of treating chronic ulcers
     
23. Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
     
24. Method for administering insulin to the buccal region
     
25. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
     
26. Synergistic composition for the treatment of diabetes mellitus
     
27. Method for screening agents for the treatment of diabetes
     
28. Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
     
29. Insulin highly respirable microparticles
     
30. Methods for the prevention against or treatment of diabetes with ETXB and/or insulin
     
31. Treatment of diabetes with milk protein hydrolysate
     
32. DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
     
33. Vasoactive intestinal polypeptide pharmaceuticals
     
34. Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes
     
35. Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
     
36. Commercial production of insulin and insulin-like protein in plants
     
37. Long acting injectable insulin composition and methods of making and using thereof
     
38. Insulin related transcription factor and uses thereof
     
39. Methods and compositions for pulmonary delivery of insulin
     
40. Treatment of type I diabetes
     
41. OCT based method for diagnosis and therapy
     
42. Rat model of diabetic nephropathy
     
43. Placental alkaline phosphatase to control diabetes
     
44. Polynucleotides encoding an isolated .beta.-islet cell two-pore domain potassium channel
     
45. Antidiabetic preparation for oral administration
     
46. Use of gp130 activators in diabetic neuropathy
     
47. Treatment of gestational diabetes
     
48. Method of detecting mild impaired glucose tolerance or insulin secretory defect
     
49. Maternal multi-nutrient against diabetes-related birth defects
     
50. Oral insulin therapy
     
51. Treatment of diabetes with synthetic beta cells
     
52. Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
     
53. Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
     
54. Processes for making acylated insulin
     
55. Inhibitors of nitric oxide synthase to treat type 1 diabetes
     
56. Night-time oral insulin therapy
     
57. Composition for measuring glucose having improved substrate specificity
     
58. GLP-1 gene delivery for the treatment of type 2 diabetes
     
59. Time-release compositions for delivery of [Cr.sub.3O(carboxylate).sub.6(H.sub.2O).sub.3].sup.+
     
60. Compositions and methods for regulated protein expression in gut
     
61. Glucose dependent release of insulin from glucose sensing insulin derivatives
     
62. Apolipoprotein biopolymer markers indicative of insulin resistance
     
63. Formulations for amylin agonist peptides
     
64. Insulin-secreting immortalized liver cell line modified by glucose sensitivity
     
65. Alcohol-free transdermal insulin composition
     
66. Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
     
67. Method and device for determining distribution of glycation of erythrocytic membranes
     
68. Therapeutic uses of Dunaliella powder
     
69. Lactoferrin in the treatment of diabetes mellitus
     
70. Means for maintenance and/or correction of glucose concentration in blood
     
71. Methods for screening compounds that modulate lipid metabolism
     
72. Periocular drug delivery for diabetic retinopathy
     
73. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
     
74. Cultured cells from pancreatic islets
     
75. Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
     
76. Methods and reagents for diagnosis and treatment of diabetes
     
77. Implantable biosensor and methods of use thereof
     
78. Method of haplotype-based genetic analysis for determining risk for developing insulin resistance and coronary artery disease
     
79. Protein biopolymer markers indicative of insulin resistance
     
80. Adipocyte Insulin adpinsl with Insulin A and B chains and an effective method of treating type 2 diabetes in a subject using adipocyte insulin
     
81. Method of cancer screening; method of cancer treatment; and method of diabetes treatment
     
82. Regulation of intracellular glucocorticoid concentrations
     
83. Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
     
84. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
     
85. INGAP protein involved in pancreatic islet neogenesis
     
86. Complement C3 precursor biopolymer markers predictive of type II diabetes
     
87. Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions
     
88. Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
     
89. Method for administering insulin to the buccal region
     
90. Inhibition of beta cell degeneration
     
91. Skeletal cell model to screen anti-diabetic compounds
    
 
92. Methods of treating diabetes by blocking VEGF-mediated activity
     
93. Use of melagatran for the manufacture of a medicament for the treatment of Type 1 diabetes mellitus
     
94. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
     
95. Lactoferrin in the treatment of diabetes mellitus
     
96. Method of delaying the onset of diabetes
     
97. Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
     
98. Exendins, exendin agonists, and methods for their use
     
99. Method for reducing food intake
     
100. Production of pancreatic islet cells and delivery of insulin
      
101. Adiponectin gene therapy
      
102. Formulation for insulin and glucose control
      
103. Inhibitors of apoptosis of nerve cells
      
104. Biologically active oral preparation that can be site-specific released in colon
      
105. Target for treating athersclerosis, obesity and type II diabetes
      
106. Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
      
107. Methods for treatment of diabetes using a peptide analogues of insulin
      
108. Antigen associated with type 1 Diabetes Mellitus
      
109. Formulation for inhalation
      
110. Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
      
111. Use of pullulan as a slowly digested carbohydrate
      
112. Pernasally absorbable insulin preparations
      
113. Transgenic mice containing glucagon receptor gene disruptions
      
114. Blood glucose modulating compositions and methods
      
115. Stable insulin formulations
      
116. Process for obtaining mammalian insulin secreting cells in vitro and their uses
      
117. Method for normalizing insulin levels
      
118. Mixtures for stimulating glucose up-take
      
119. Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor
      
120. Composition and method for reducing blood glucose
      
121. Compositions and methods for the treatment or prevention of autoimmune diabetes
      
122. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
      
123. Once-a-day controlled release sulfonylurea formulation
      
124. Prevention of diabetes and prolongation of the honeymoon phase of diabetes by administration of GnRH antagonists
      
125. Methods for glucagon suppression
      
126. Method of treating diabetes using plant argyrolobium roseum extract, and a process for the isolation of extract from the said plant
      
127. Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
      
128. Process for the preparation of amylase inhibitor
      
129. Compositions and methods for treatment for glucose metabolism disorders
      
130. Systemic administration of a therapeutic preparation
      
131. Methods for protecting against autoimmune diabetes
      
132. Pulmonary administration of chemically modified insulin
      
133. Methods of making pancreatic islet cells
      
134. Composition and method for the treatment of dysglucaemia
      
135. Pancreatic islet cell antigens obtained by molecular cloning
      
136. Compositions containing polysaccharides from phellinus linteus and methods for treating diabetes mellitus using same
      
137. Regulated autocrine growth of mammalian cells
      
138. Use of coxiella bacteria to treat autoimmune disease
      
139. Method for treating symptoms of diabetes
      
140. Microencapsulated pancreatic islet cells
      
141. Herbal compositions and methods for diabetes and weight loss management
      
142. Carbohydrate system and a method for providing nutrition to a diabetic
      
143. Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
      
144. Medicinal herbal compounds for the prevention and treatment of diabetes
      
145. Compositions and methods for treating diabetes
      
146. Culturing pancreatic stem cells having a specified, intermediate stage of development
      
147. Product derived from milk substantially free of beta casein from non-human mammals and relative use
      
148. Advanced glycation end-product intermediaries and post-amadori inhibition
      
149. Methods and compositions for the pulmonary delivery insulin
      
150. Detecting genetic predisposition to sight-threatening diabetic retinopathy
      
151. Animal model
      
152. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
      
153. Composition and method for maintaining blood glucose level
      
154. Method of treating or preventing Type 1 diabetes by oral administration of insulin
      
155. Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
      
156. Agent for ameliorating pancreatic function disorder
      
157. Methods and compositions for pulmonary delivery of insulin
      
158. Treatment of diabetes mellitus
      
159. Regulators of PPAR.delta. (.beta.) and their use in the treatment of obesity and insulin resistance
      
160. Transdermal delivery system
      
161. Bystander suppression of type I diabetes by oral administration of glucagon
      
162. Human glucose-dependent insulin-secreting cell line
      
163. Platform for the differentiation of cells
      
164. Single-chain insulin analog and a polynucleotide sequence encoding the analog
      
165. Islet cell antigen 1851
      
166. Diagnostic screens for type 1 diabetes (IDDM)
      
167. System and method for treating eye and nerve diseases in diabetic and non-diabetic patients
      
168. Insulin C-peptides
      
169. Methods and compositions for treatment of diabetes and related conditions via gene therapy
      
170. Method for treating heart disease and cardiovascular disease in diabetic and non-diabetic patients
      
171. Treatment for diabetes
      
172. Method for treating, controlling, and preventing Diabetes Mellitus
      
173. Stable insulin formulations
      
174. Medicinal aerosol formulation
      
175. Once-a-day controlled release sulfonylurea formulation
      
176. Immunoassay for measuring human C-peptide and kit therefor
      
177. In vivo production and delivery of insulinotropin for gene therapy
      
178. Insoluble compositions for controlling blood glucose
      
179. Method for determining whether a compound is an insulin receptor kinase activator
      
180. Composition and method for improved carbohydrate management in mammals
      
181. Method of treating insulin resistance
      
182. Long lasting synthetic glucagon like peptide {GLP-!}
      
183. Detection methods for type I diabetes
      
184. Device for treating diabetes and methods thereof
      
185. Method for the improvement of islet signaling in diabetes mellitus and for its prevention
      
186. Biphasic controlled release delivery system for high solubility pharmaceuticals and method
      
187. Hepatocyte growth factor for treatment of diabetes
      
188. Peroral dosage form for peptide containing medicaments, in particular insulin
      
189. Insoluble insulin compositions
      
190. Spray-drying process for the preparation of microparticles
      
191. Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
      
192. Fatty acid-acylated insulin analogs
      
193. Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
      
194. Method for administering insulin
      
195. Treatment for diabetic complications
      
196. Neurotoxin therapy for diabetes
      
197. Composition for treatment of diabetes and treatment of diabetes
      
198. Formulations for amylin agonist peptides
     
     
199. Insulin supplemented infant formula
     
     
200. Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
     
     
201. Metformin-containing compositions for the treatment of diabetes
     
     
202. Insulin supplemented infant formula
     
     
203. DNA and peptides of a diabetes-specific endogenous retrovirus
     
     
204. Use of zinc tranexamate in the treatment of diabetes
     
     
205. Prediction of diabetes impaired wound healing by urinary nitrate assay
     
     
206. Prolonging survival of transplanted pancreatic cells 
     
     
207. Therapeutic food composition and method to diminish blood sugar fluctuations
      
     
208. Methods for treating diabetes
      
     
209. Method for administering acylated insulin
      
     
210. Method for restoring glucose responsiveness to insulin secretion
      
     
211. Prediction of diabetes impaired wound healing by urinary nitrate assay
      
     
212. Pulmonary insulin crystals
      
     
213. Method for detecting or monitoring the effectiveness of treatment of T cell mediated diseases
      
     
214. Therapeutic preparation for inhalation
      
     
215. Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals
      
     
216. Mumbaistatin, a process for it's production and its use as a pharmaceutical
      
     
217. Treatment for juvenile diabetes
      
     
218. Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II
      
     
219. Insoluble insulin compositions
      
     
220. Methods and compositions for increasing insulin sensitivity
      
     
221. Insulin-like growth factor agonist molecules
      
     
222. Diabetic nutritionals and method of using
      
     
223. Adult-onset diabetes treatment method
      
     
224. Composition for improving pancreatic function
      
     
225. Insulin derivatives having a rapid onset of action
      
     
226. Composition and method for increasing insulin activity
      
     
227. Stabilized insulin compositions
      
     
228. Diabetic supplement bar

Treatment, Dialysis

1. Solid preparation for dialysis and process for producing the same
    
2. Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
    
3. Amino acid composition for hemodialysis
    
4. Solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same
   
   
5. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
    
   
6. Solution for peritoneal dialysis

Treatment, Diaper Rash

1. Composition and method for treating diaper rashes and skin irritations caused by acidic secretions
    
2. Composition and method for the treatment of diaper rash using natural products

Treatment, Diarrhea/Antibiotic Associated Diarrhea

1. Methods of treating travelers diarrhea and hepatic encephalopathy
    
2. Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli
    
3. Intranasal vaccine for use against disease caused by enterotoxigenic Escherichia coli
    
4. Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
    
5. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
    
6. Attenuated human rotavirus vaccine
    
7. Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins
    
8. Anti diarrhoea compositions
    
9. Lactic acid bacteria strains capable of preventing diarrhoea
    
10. Oral rehydration compositions
     
11. Combinant polypeptide for use in the manufacture of vaccines against Campylobacter induced diarrhea and to reduce colonization
     
12. Isolation, characterization, cloning and use of a mushroom lectin
     
13. Treatment of diarrhea with strains of Bifidobacterium longum
     
14. Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells
     
15. Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
     
16. Antibodies to cryptosporidium
     
17. Methods and compositions for prevention and treatment of Clostridium difficile-associated diseases
     
18. Treatment of C. difficile toxin B associated conditions

Treatment, Diphtheria

1. Multi-mutant diphtheria toxin vaccines

Treatment, Down's Syndrome

1. Methods for inhibiting cognitive deterioration in adults with down's syndrome
    
2. Biochemical test for identifying pregnancies with Down's syndrome fetus
    
3. Human methionine synthase reductase: cloning, and methods for evaluating risk of, preventing, or treating neural tube defects, cardiovascular disease, cancer, and down's syndrome
    
4. Methods for identifying chromosomal aneuploidy
    
5. Prenatal screening for Down's syndrome using hyperglycosylated gonadotropin

Treatment, Drug/Alcohol Addiction/Related Disorders

1. Enhancement of alcohol metabolism
    
2. Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances
    
3. Pharmaceutical compositions for prevention of overdose or abuse
    
4. Methods for modulating a drug-related effect or behavior
    
5. Flumazenil for the treatment of alcohol dependency
    
6. Method for the accelerated in vivo removal of ethanol
    
7. Asafetida extract as medicine for abstinence of drugs
    
8. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
    
9. Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
    
10. Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
     
11. Anti-cocaine catalytic antibody
     
12. Treatment of addiction and addiction-related behavior using a composition of topiramate
     
13. Use of CDP-choline for the treatment of alcohol withdrawal syndrome
     
14. Treatment of addiction and addiction-related behavior
     
15. Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies
     
16. Method and composition for the accelerated in vivo removal of ethanol
     
17. Pramipexole as a treatment for cocaine craving
     
18. Vaccine and immunserum against drugs of abuse
     
19. 5-HT3 receptor assay using transgenic mammal
     
20. Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
     
21. Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
     
22. Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms
     
23. Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator
     
24. Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
     
25. Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances
     
26. Galenic composition containing opioid antagonists
     
27. Method of preparing and using isoflavones for the treatment of alcoholism
    
    
28. Anti-cocaine vaccine
    
    
29. Mu-opiate receptor peptides
     
    
30. Mediating the effects of alcohol consumption by orally administering active dry yeast
     
    
31. Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Treatment, Drug Induced Toxicity

1. Delivery of a therapeutic agent in a formulation for reduced toxicity
    
2. N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
    
3. Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity

Treatment, Drug Overdose/Intoxication

1. Rescue agents for treating botulinum toxin intoxications
    
2. Compositions and method for treatment of acetaminophen intoxication

Treatment, Dwarfism/Achondroplasia

1. Therapeutic agents for achondroplasia
    
2. Composition for sustained release of human growth hormone

Treatment, Dysautonomic Conditions/Riley-Day Syndrome

1. Method for diagnosing and treating dysautonomia and other dysautonomic conditions

Treatment, Dysmenorrhea

1. Warming and nonirritating lubricant compositions and method of comparing irritation
    
2. Warming and nonirritating lubricant compositions and method of comparing irritation
    
3. Medicinal composition for treating dysmenorrhea and endometriosis industrial use

Treatment, Ear/Auditory, Related Disorders

1. Method and composition for treating ear inflammation caused by dry ear
    
2. Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
    
3. Haemophilus influenzae type IV pili
    
4. Therapeutic agents for inner ear disorders containing an IL-6 antagonist as an active ingredient
    
5. Therapeutic use of methionine-derivitives to reduce the toxicity of noise
    
6. Drug for auditory dysfunction
    
7. Drug delivery to the inner ear and methods of using same
    
8. Treatment of optic and otic inflammation
    
9. Stimulation of cellular regeneration and differentiation in the inner ear
    
10. Method of promoting healing of a tympanic membrane perforation
     
11. Otic microbial combination for treatment of animals with ruptured tympanic membrane
     
12. Treatment of inner ear hair cells
     
13. Treatment of inner ear hair cells
     
14. Compositions and method for relieving discomfort in the ears
     
15. Moraxella catarrhalis BASB034 polypeptides and uses thereof
     
16. Treatments for immune-mediated ear disorders

Treatment, Eating Disorders

1. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
    
2. Composition and method for inducing satiety

Treatment, Ectopic Calcification

1. Methods of inhibiting ectopic calcification

Treatment, Edema Related Disorders

1. Methods for reducing edema
    
2. Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
    
3. Method and topical compound for treatment of edema

Treatment, Elastic Fiber Injury

1. Method for the prevention of tissue elastic fiber injury

Treatment, Embolizations

1. Process for embolization using swellable and deformable microspheres
    
2. High viscosity embolizing compositions
    
3. High viscosity embolizing compositions comprising prepolymers
    
4. Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
    
5. Method of embolization using polyvinyl alcohol microspheres

Treatment, Emphysema

1. Methods for treatment of Emphysema using 13-cis retinoic acid

Treatment, Encephalitis, Tick-Borne/Japanese/Others

1. Vaccines against Japanese encephalitis virus and West Nile virus
    
2. Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus
    
3. Nucleic acid vaccines for prevention of flavivirus infection
    
4. Diagnostic assay for transmissible spongiform encephalopathies
    
5. Antibodies specific for native PrPsc
    
6. Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same
    
7. Chimeric vaccine against tick-borne encephalitis virus
    
8. DNA vaccines against tick-borne flaviviruses

Treatment, Endocrine/Pituitary Related Disorders

1. 7B2 knockout transgenic animals as models of endocrine disease
    
2. Methods of screening for compounds that bind to activin receptor
    
3. Compositions and methods for treating gonadotrophin related illnesses
    
4. Method for treating endocrine disorders

Treatment, Endometriosis/Endometrial Related Disorders

1. Phytochemicals for treatment of endometriosis
    
2. Composition for treatment or prevention of endometrial cancer and method of preventing or treating endometrial cancer using the composition
    
3. Polypeptide autoantigens associated with endometriosis
    
4. Chimeric mouse model for endometriosis
    
5. Preventives or remedies for endometriosis or uterine myoma
    
6. Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
    
7. Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
    
8. Treating endometriosis or infertility, or improving fertility
    
9. Use of prothymosin in the diagnosis and treatment of endometriosis
    
10. Tumor necrosis factor antagonists and their use in endometriosis
     
11. Medicinal composition for treating dysmenorrhea and endometriosis industrial use

Treatment, Epilepsy/Other Seizure Related Disorders

1. Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
    
2. Methods of treatment using a gastric retained gabapentin dosage
    
3. Intracranial botulinum toxin therapy for focal epilepsy
    
4. Lafora's disease gene
    
5. Mass1 gene, a target for anticonvulsant drug development
    
6. Process for preparing non-hygroscopic sodium valproate composition
    
7. Controlled release formulation of divalproex sodium

Treatment, Estrogen Related Disorders

1. Therapy of estrogen-associated disorders

Treatment, Fahr Disease

1. Functional improvements in Fahr disease

Treatment, Fetal Development Related Disorders

1. Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
    
2. Method of observing vasculogenesis in vitro using cultured allantois
    
3. IgM antibodies to the 70 kDa heat shock protein as a marker for cytomegalovirus infection

Treatment, Fibromyalgia

1. Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
    
2. Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
    
3. Botulinum toxin therapy for fibromyalgia
    
4. Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders
    
5. Use of ribose to treat fibromyalgia
    
6. Methods for treating fibromyalgia
    
7. Treatment of fibromyalgia with ubiquinone 10 and succinic acid

Treatment, Fibrosis, Organ/Tissue

1. Wound healing and treatment of fibrosis
    
2. Procollagen (III) propeptides and related substances for treating fibrotic diseases
    
3. Copper lowering treatment of inflammatory and fibrotic diseases
    
4. Method of treating fibrosis
    
5. Copper lowering treatment of inflammatory and fibrotic diseases
    
6. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
    
7. Use of sex steroids function modulators to treat wounds and fibrotic disorders
    
8. Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
    
9. Use of strains of parapoxvirus ovis against organ fibrosis

Treatment, Foodborne Infection

1. Method of detecting norwalk-like virus (GII)
    
2. Bacterial superantigen vaccines
    
3. Control of microbial populations in the gastrointestinal tract of animals

Treatment, Free Radicals, Blocking

1. Method of treating diseases caused by over-production of free-radicals
    
2. Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions

Treatment, Gastroenteritis

1. Methods of treating necrotizing enterocolitis
    
2. Transgenic plant-based vaccines
    
3. Polynucleotides encoding porcine transmissible gastroenteritis virus
    
4. Method for diagnosing atrophic gastritis
    
5. Methods for producing recombinant coronavirus
    
6. Helicobacter pylori adhesin binding group antigen
    
7. Serum-free, low-protein media for rotavirus vaccine production
    
8. Rotavirus subunit vaccine
    
9. Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers
    
10. Monoclonal antibodies against Campylobacter jejuni and Campylobacter coli outer membrane antigens

Treatment, Gastrointestinal Related Disorders/Cancer

1. Method to maintain the efficacy of orlistat
    
2. Exendins and exendin agonist analogs to regulate gastrointestinal motility
    
3. Methods of treating necrotizing enterocolitis
    
4. Anti-inflammatory and/or analgesic composition for the intestine comprising branched maltodextrins
    
5. Bile preparations for gastrointestinal disorders
    
6. Enzyme treatment of foodstuffs for Celiac Sprue
    
7. Breast, gastric and prostate cancer associated antigens and uses therefor
    
8. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
    
9. Method for treating inflammatory diseases of the digestive tract
    
10. Saccharide compositions and method of use
     
11. Host receptor for pathogenic bacteria
     
12. Helicobacter pylori CAI antigen
     
13. System, formulation, kit and method for tagging colonic residue in an individual
     
14. Methods of enhancing functioning of the large intestine
     
15. Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans
     
16. Pharmaceutical compositions for bioactive peptide agents
     
17. Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
     
18. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin 
     
19. Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
     
20. Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
     
21. Methods for treating gastroesophageal reflux disease
     
22. Simethicone containing tablet composition and method
     
23. Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
     
24. Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
     
25. Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
     
26. Methods of treating intestinal ischemia using heparin-binding epidermal growth factor
     
27. Methods for treating ulcers and gastroesophageal reflux disease
     
28. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
     
29. Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
     
30. Methods of enhancing functioning of the large intestine
     
31. Use of lipid conjugates in the treatment of diseases
     
32. Stable pharmaceutical composition useful for treating gastrointestinal disorders
     
33. Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
     
34. Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
     
35. Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
     
36. Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
     
37. Stimulating neutrophil function to treat inflammatory bowel disease
     
38. Implantable particles for the treatment of gastroesophageal reflux disease
     
39. Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
     
40. Chewable compositions containing a gel-forming extract of psyllium
     
41. Control of acidosis
     
42. Micro-organisms with glycosylation modulating action of intestinal cell surface
     
43. Method of analyzing intestinal flora and analytical apparatus
     
44. Capsules containing vital cells or tissues
     
45. Methods and compositions for treating gastroparesis
     
46. Treatment of gastrointestinal stromal tumors
     
47. Method for treating gastric disorders using optically pure (-) pantoprazole
     
48. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
     
49. Unfermented gel fraction from psyllium seed husks
     
50. Treatment of diarrhea with strains of Bifidobacterium longum
     
51. Salmonella vaccine materials and methods
     
52. Treatment of dyspepsia
     
53. Compositions and methods for treating ileus
     
54. Immunogenic compositions against gastrin peptides
     
55. Methods for regulating gastrointestinal motility
     
56. Probiotic mixture intended for monogastric animals to control intestinal flora populations
     
57. Method for maintaining or improving the synthesis of mucins
     
58. Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
     
59. Methods of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
     
60. Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
     
61. Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
     
62. Substituted benzimidazole dosage forms and method of using same
     
63. Antibodies to cryptosporidium
     
64. Nasal administration of agents for the treatment of gastroparesis
     
65. Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
     
66. Reduction of heartburn episodes after ingestion of orange juice
     
67. Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
     
68. Methods for sterilizing preparations of digestive enzymes
     
69. Treatment of helicobacter with isothiocyanates
     
70. Use of interleukin-11 to treat gastrointestinal disorders
     
71. Method for screening the risk of gastric cancer
     
72. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
     
73. Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
     
74. Reduction of heartburn episodes upon ingestion of orange juice
     
75. Passive immunization against clostridium difficile disease
     
76. Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors
     
77. Treatment of gastro-intestinal disorders
     
78. Intestinal function using leptin
     
79. Herbal formulation which acts as an intestinal bowel soother
     
80. Compositions for treatment of disorders of the oesophagus
     
81. Solid dose forms containing bismuth
     
82. Rotavirus subunit vaccine
     
83. Methods of enhancing functioning of the large intestine
     
84. Intraperitoneal administration of adenosine for the treatment of prevention of gastrointestinal of systemic diseases
     
85. Preventives/remedies for inflammatory intestinal disease
     
86. Method and compositions for the control or eradication of Helicobacter pylori
     
87. Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
     
88. Use of metal complexes to treat gastrointestinal infections
     
89. Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
     
90. Method of treating inflammatory bowel disease using a topical formulation of IL-11
     
91. Coated chewing gum products containing an acid blocker and process of preparing
     
92. Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
     
93. Recombinant Sef14 fimbrial protein from Salmonella
     
94. Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers
     
95. Fiber blend for enteral composition
     
96. Method for eradication of Helicobacter pylori
     
97. Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen
     
98. Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
     
99. Zymogen activation system
     
100. Composition for treatment of a bacterial infection of the digestive tract
     
     
101. Pourable alginate compositions
     
     
102. Methods of treating intestinal ischemia using heparin-binding epidermal growth factor
     
     
103. Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
     
     
104. Monitoring gastrointestinal function to guide care of high risk patients
     
     
105. Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
     
     
106. Double capsule for the administration of active principles in multiple therapies
     
     
107. Method for treating celiac disease
     
     
108. Alteration of microbial populations in the gastrointestinal tract
     
     
109. Control of microbial populations in the gastrointestinal tract of animals 
     
     
110. Food for inhibiting infection and treating gastritis, gastric and duodenal ulcers
      
     
111. Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease
      
     
112. Control of acidic gut syndrome
      
     
113. Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract
      
     
114. Unfermented gel fraction from psyllium seed husks
      
     
115. Non-invasive test for assessing bacterial overgrowth of the small intestine
      
     
116. Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection
      
     
117. Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
      
     
118. Pharmaceutical antacid
      
     
119. Lactulose-based anhydrous composition
      
     
120. Nutritional composition for treating inflammatory bowel diseases
      
     
121. Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
      
     
122. Non-aqueous colonic purgative formulations
      
     
123. Intestinal juice level regulator
      
     
124. Antacid composition

Treatment, Gaucher Related Disorders

1. Methods of treating lysosomal storage related diseases by gene therapy
    
2. Recombinant α-galactosidase A therapy for Fabry disease
    
3. Products and methods for gaucher disease therapy